You Position: Home > Paper

Intravitreous injiection with triamcinolone acetonide for diffused diabetic macular edema

( views:355, downloads:197 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
Issue:
4
DOI:
10.3760/j.issn:1005-1015.2005.04.005
Key Word:
黄斑水肿,囊样/药物疗法;曲安奈德/治疗应用;糖尿病/并发症

Abstract: 目的观察玻璃体内注射曲安奈德(TA)治疗糖尿病性弥漫性黄斑水肿的疗效.方法21例经眼底检查、荧光素眼底血管造影(FFA)和光相干断层扫描(OCT)检查确诊的糖尿病性弥漫性黄斑水肿患者接受玻璃体内注射40 mg/ml的TA0.1 ml治疗,随访1、3、6个月,对比观察治疗前后患眼视力、眼压以及黄斑区视网膜厚度的变化.视力用ETDRS视力表检查;眼压用非接触眼压计检查;视网膜厚度用OCT检查. 结果注药后1个月时视力平均提高7.5个字母,OCT检查黄斑区视网膜厚度平均降低143μm,下降了33%.3个月时视力平均提高9.1个字母,10只眼提高2行以上,占48%,视网膜厚度平均降低184μm,下降了42%.6个月时视力平均提高5.1个字母,视网膜厚度降低了151μm,下降了35%.结论玻璃体内注射TA治疗糖尿病性弥漫性黄斑水肿短期内安全有效.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn